Breast Cancer News
In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Women 65 and older are less likely to survive breast cancer than their younger counterparts, two recent studies suggest.
NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.
NEW YORK (Reuters Health) - One in four women who have breast-conserving surgery for cancer needs a second operation to remove more breast tissue, suggests a new study that also found the rate of re-operation varied widely by surgeon.
Learn how the Oncotype DX DCIS Score predicts recurrence and adds treatment options in early-stage breast cancer.
If you have been diagnosed with early-stage breast cancer and are exploring your treatment options, learn why axillary surgery may not be necessary.
(Reuters) - Women who get a quicker, localized form of radiation treatment for early-stage breast cancer are more likely to need to have their breast removed later on than women treated with traditional radiation of the whole breast.
If you have been diagnosed with HER2 positive, early-stage breast cancer, find out how you and your healthcare team can reduce the risk of heart-damaging side effects potentially caused by some chemotherapy treatments.
CHICAGO (Reuters) - Women who survive breast cancer after undergoing chemotherapy may also have to contend with impairments in attention, memory and planning skills, U.S. researchers said on Monday.
NEW YORK (Reuters Health) - Although fewer and fewer women have died of breast cancer each year over the past two decades, a new study suggests that improvements in survival have been slowest for the oldest women with the disease.
In a five-year review of 20 clinical trials, tamoxifen was shown to safely reduce both 15-year risk for recurrence and death in early-stage estrogen receptor-positive breast cancer.